Interferon-α plus ribavirin in chronic hepatitis C resistant to previous interferon-α course: results of a randomized multicenter trial
- 31 May 1999
- journal article
- clinical trial
- Published by Elsevier
- Vol. 30 (5) , 788-793
- https://doi.org/10.1016/s0168-8278(99)80130-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: Results of a randomized, controlled trialHepatology, 1998
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centersJournal of Hepatology, 1997
- Modulation of hepatitis C virus quasispecies heterogeneity by interferon‐α and ribavirin therapyJournal of Viral Hepatitis, 1997
- Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patientsJournal of Medical Virology, 1995
- Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis CJournal of Hepatology, 1994
- Retreatment with interferon-α of chronic hepatitis C virus infectionThe Lancet, 1994
- Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferonJournal of Hepatology, 1993
- Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis CJournal of Medical Virology, 1993
- Avoiding false positives with PCRNature, 1989
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981